
Julius Stone Lecturer
Akiko Iwasaki, PhD
Yale School of Medicine
Title: Immune Responses to SARS-CoV-2

Herman Beerman Lecturer
Neil H. Shubin, PhD
University of Chicago
Title: TBA

William Montagna Lecturer
Daniel Kaplan, MD/PhD
University of Pittsburgh
Title: Cutaneous Neurons Modulate Skin Inflammation

Eugene M. Farber Lecturer
April Armstrong, MD/MPH
Keck School of Medicine at the University of Southern California (USC)
Title: Getting Clear: Psoriasis Advancements and Beyond

Naomi M. Kanof Lecturer
Mary Margaret “Meg” Chren, MD
Vanderbilt University Medical Center
Title: TBA

Stephen Rothman Memorial Awardee
Paul Khavari, MD/PhD
Stanford University

State-of-the-Art Plenary Lecture # 1
Julia Oh, PhD
The Jackson Laboratory
Title: From Metagenomes to Therapeutics: The Landscape of the Human Skin Microbiome

State-of-the-Art Plenary Lecture # 2
Ya-Chieh Hsu, PhD
Harvard Stem Cell Institute
Title: Skin Deep: Stem Cells at the Nexus of the Niche, Physiology, and the External Environment

State-of-the-Art Plenary Lecture # 3
Isaac Brownell, MD/PhD
NIAMS, NIH
Title: Merkel Cells and Merkel cell Carcinoma – Neuroendocrine Skin Cells from Development to Cancer

State-of-the-Art Plenary Lecture # 4
Donald Glass, MD/PhD
University of Texas Southwestern Medical School
Title: Keloids: Aberrant Wound Healing/Inflammatory Fibroproliferative Disorder

State-of-the-Art Plenary Lecture # 5
C. Henrique Serezani, PhD
Vanderbilt University Medical Center
Title: Understanding Skin Host Defense in Health and Disease

State-of-the-Art Plenary Lecture # 6
Shuai “Steve” Xu, MD/MSc
Northwestern University
Title: Digital Dermatology

Plenary Sessions # 1-4
Plenary Sessions # 1-4 are a showcase of submitted abstracts that the Scientific Program Chairs and organizers felt were the most representative of the most cutting edge science, reflect a diversity of topics and speakers, and was scored highly amongst the abstract reviewers (among other things).
Each Plenary Session will run for one hour in length and will offer both the talk and a Q&A period immediately afternoon. A more detailed schedule of Plenary Sessions # 1-4 will be listed in mid-February 2021.